We have conducted regulatory due diligence in connection with the acquisition of a pharmacy, covering compliance with applicable pharmaceutical and healthcare legislation.
Updates
Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.
Type
Sectors (1)
Expertises (2)
Advertising and Claims
Commercial Contracts
Corporate, Governance and Boardroom Counselling
Data Protection, (Cyber)security and AI
Due Diligence
Environmental and Sustainability
Financing and M&A
Intellectual Property and Licensing
Litigation
Regulatory Compliance and Enforcement
Spin-out and Starter Advisory
Subsidies and Grants
Healthcare
Remove filter
Corporate, Governance and Boardroom Counselling
Remove filter
Due Diligence
Remove filter
Clear all
3 results
Newest first
Healthcare
Pharmaceuticals
Due Diligence
Regulatory Compliance and Enforcement
Testimonial
Diagnostics
Healthcare
Corporate, Governance and Boardroom Counselling
Financing and M&A
Testimonial
Axon assisted a Dutch IVD company in securing a EUR 24M equity financing round, advising on the transaction structure, investment documentation and related matters.
Healthcare
Corporate, Governance and Boardroom Counselling
Financing and M&A
Testimonial
Axon assisted a Dutch oncology company, developing small molecule inhibitors for the precision treatment of cancer, with the structuring and completion of its Series A financing round. We advised on the drafting of all corporate resolutions, conditions precedent and related filtering and closing matters.